LONDON, March 18, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce the results of a real-world study from Spain that showed how a ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN♢ COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance backed ...
Smith + Nephew SNN recently launched ALLEVYN COMPLETE CARE Foam Dressing, a next-generation solution designed to support both wound management and pressure injury prevention. For investors, the launch ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI - leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence ...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research ...
ALLEVYN™ LIFE, a silicone foam dressing also indicated for the treatment and prevention of pressure ulcers, developed by Smith & Nephew, was introduced to the protocol as part of the standard ...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce exciting new data from Professor Amit Gefen and his research group published in the International Wound ...
ST. PETERSBURG, Fla., April 16 /PRNewswire-FirstCall/ -- The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results